BusinessGlobal Blood Therapeutics to Present at the 35th Annual J.P. Morgan Healthcare ConferenceBy Nasdaq OMXJan 3, 2017, 9:06 PM UTC
BusinessGlobal Blood Therapeutics Added to NASDAQ Biotechnology IndexBy Nasdaq OMXDec 16, 2016, 1:30 PM UTC
BusinessGlobal Blood Therapeutics Announces Upcoming Investor Webcast to Review GBT440 Data Being Presented at ASH that Support Sickle Cell Disease ProgramBy Nasdaq OMXNov 30, 2016, 9:05 PM UTC
BusinessGlobal Blood Therapeutics Announces Pivotal Study for GBT440 in Sickle Cell Disease with Primary Hemoglobin EndpointBy Nasdaq OMXOct 24, 2016, 8:06 PM UTC
BusinessGlobal Blood Therapeutics Announces Appointment of Tricia Suvari as Chief Legal OfficerBy Nasdaq OMXOct 12, 2016, 12:00 PM UTC
BusinessGlobal Blood Therapeutics Joins Sickle Cell Disease (SCD) Coalition in Support of SCD Community with Goal to Improve Treatment and CareBy Nasdaq OMXSep 6, 2016, 1:05 PM UTC
BusinessGlobal Blood Therapeutics Announces Participation at Two Upcoming Investor Conferences in SeptemberBy Nasdaq OMXAug 31, 2016, 8:05 PM UTC
